Skip to main content
letter
. 2018 Oct;103(10):e440–e442. doi: 10.3324/haematol.2018.190967

Figure 1.

Figure 1.

Changes of hemoglobin F levels among study participants. Arrows indicate the time at which metformin therapy was started and ended. Cases from 1 to 3 and from 4 to 7 represent patients with polycystic ovarian syndrome and type 2 diabetes, respectively.